ICON Insights
BioPharma companies and Medical Device manufacturers face growing operational, regulatory and economic challenges. ICON provides analysis and key insights on these challenges, with practical advice and recommendations.
Thought Leadership
- Transforming TrialsThe traditional clinical development model needs to change.
- Value Based DevelopmentThe traditional healthcare delivery model is changing.
- Digital DisruptionTechnologies that accelerate and improve Clinical Trials.
- Patient CentricityPatients are now better informed on clinical options than they ever have been.
Patient Centricity
Patients are now better informed on clinical options than they ever have been.
ExploreInsight Topics
Increasing Complexity and Declining ROI in Drug Development
Perspectives from Senior Pharma Executives
Flow Cytometry for Driving Trials Forward
Engage assay experts with unparalleled experience and expertise
Impact of Artificial Intelligence on Outcomes Based Contracting
Understanding the challenges for formulary decision makers and manufacturer
Key Considerations in Chronic Pain Clinical Trials
Determine the right design, assessments and endpoints in your pain study
MDR/IVDR brings higher costs and bottlenecks
Develop the right business strategy to successfully navigate MDR/IVDR
The Role of ICER as an Independent HTA Organisation
primary research evaluating ICER’s influence over payers and manufactures
Drug Safety Reporting
Increasing efficiency through automation
Personalising Digital Health
Develop an integrated, patient centric approach to harnessing Digital Health technologies
Making Sense of the Biosimilars Market
Get the insights you need for successful biosimilar commercialisation
Investigator Payments
Global Investigator Payments Solutions
Regulatory Intelligence Newsletter
ICON’s monthly Regulatory Intelligence Newsletter
CDISC Data Standardisation
Legacy Data Conversion
Wearables
Remote monitoring and leveraging wearable devices and sensors in clinical trials.
Adaptive Design: The Faster Path to Market
An adaptive design clinical trial can help to create a stronger value proposition for your medical device by reducing development costs and accelerating time-to-market.